Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-15

Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids [NA]

View source ↗

Summary

A clinical trial evaluating MR-guided focused ultrasound (MRgFUS) versus myomectomy for uterine fibroids has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: InSightec | Conditions: Uterine Fibroids, Bleeding | NA | Status: WITHDRAWN